Efficacy and Safety of Heterologous and Homologous COVID-19 Vaccination

NCT05074368 · clinicaltrials.gov ↗

NA

Phase

COMPLETED

Status

499

Enrollment

OTHER

Sponsor class

Conditions

Healthy Adult Volunteers

Interventions

BIOLOGICAL: ChAdOx1-nCov-19 (Astra-Zeneca)
BIOLOGICAL: SARS-CoV-2 messenger RNA-1273 (Moderna) vaccine

Sponsor

National Taiwan University Hospital

Collaborators

[object Object]